Vacancy rates climb and leasing activity slows in the Pacific Northwest hub, reflecting broader industry challenges Seattle’s life sciences real estate market is...
ByThe RegistryNovember 12, 2025Quarterly loss and major asset write-downs signal ongoing challenges for pioneering life science REIT Alexandria Real Estate Equities reported its fourth consecutive quarterly...
ByThe RegistryOctober 28, 2025Market absorption lags despite venture capital rebound to $998M in 2025, up 90.5 percent from prior year Seattle’s life sciences real estate market...
ByThe RegistryOctober 15, 2025The sector shows mixed signals with surging venture funding, but climbing vacancy rates and stalled construction projects Seattle’s life sciences real estate market...
ByThe RegistryOctober 13, 2025Alexandria Real Estate Equities (ARE), a pure-play life science REIT, reported its Q1 2025 earnings on April 29th with mixed results that suggest...
ByThe RegistryMay 14, 2025By Kate Snyder The life science industry continues to normalize after the past couple of years of increased growth. A recent report from...
ByThe RegistryMarch 6, 2023 
Signup for news and special announcements!
You have successfully joined our subscriber list.